This study proposes to assess the efficacy of Cosyntropin Injectable Suspension, 1 mg/mL
compared to vigabatrin. Additionally, this study proposes to determine efficacy of
combination therapy of Cosyntropin Injectable Suspension, 1 mg/mL and vigabatrin to
monotherapy Cosyntropin Injectable Suspension, 1mg/mL in children with new onset infantile
spasms (IS).
Phase:
Phase 3
Details
Lead Sponsor:
University of Colorado, Denver
Collaborators:
Pediatric Epilepsy Research Foundation West Therapuetics, Inc